Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-23

Clinical Trial Update: Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol [Phase 4]

View source ↗

Summary

Phase 4 trial comparing induction methods (oxytocin vs misoprostol) in pregnant women with prelabor rupture of membranes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Prelabor Rupture of Membranes | Phase 4 | Status: COMPLETED